From: Applications of CYP-450 expression for biomonitoring in environmental health
Xenobiotics | Exposure biomarkera | CYPs | Associationsb | Biospecimensa | References |
---|---|---|---|---|---|
Polycyclic aromatic hydrocarbons (PAHs) | BaP-DNA adducts | CYP1A1*- and CYP1B1** – total RNA | ↑ | NHMECs | Keshava et al. [89] |
 | CYP1A2 activity | - | Human lymphocytes | Funck-Brentano et al. [22] | |
BPDE-DNA adducts | CYP1A1 activity** | ↑ | Human lung tissue | Alexandrov et al. [28] | |
3-NBA-DNA adducts | CYP3A4** and CYP1A1 activity | ↑ and -, respectively | V79 cell lines | Bieler et al. [35] | |
 | CYP2C9 activity** | ↑ | Human B-lymphoblastoid MCL-5 | Arlt et al. [33] | |
3-ABA-DNA adducts | CYP1A1**, CYP1A2** activity | ↑ | Human B-lymphoblastoid MCL-5 | Arlt et al. [34] | |
4-ABP-Hb adducts | CYP1A2 activity** | ↑ | Human Peripheral blood | Sarkar et al. [73] | |
 | CYP1A2 activity | ↑ | Urine | Landi et al. [75] | |
Bulky-DNA-adducts | CYP1A1 mRNA | ↓ | Human placenta tissue | Whyatt et al. [27] | |
 | CYP1A1, CYP2C and CYP3A4 activity** | All ↑ | Human larynx tissue | Kap-Soon et al. [10] | |
 | CYP1B1 and CYP3** protein | - and ↑, respectively | Human BAL sample | Piipari et al. [30] | |
 | CYP1A1 total RNA** | ↑ | Human lung tissue in NSCLC | Mollerup et al. [29] | |
AhR/ ARNT | CYP1B1 total RNA** | ↑ | Human lymphocytes | Lin et al. [18] | |
 | CYP1A2 protein | ↑ | LS180 cell lines | Li et al. [20] | |
AhR | CYP1B1 mRNA | ↑ | MOG-G-CCM cells | McFadyen et al. [16] | |
 | CYP1A1** and 1B1** protein | All ↑ | Lung tissues in adenocarcinoma | Chang et al. [17] | |
 | CYP1A1** mRNA | ↑ | Human pheripheral blood | Hayashi et al. [19] | |
1-OHP | CYP1B1 mRNA | ↑ | Human pheripheral blood | Hanaoka et al. [90] | |
 | CYP1A1, CYP1B1, CYP1A2 activity | all ↑ | BTI-TN-5B1-4 cells | Kim et al. [21] | |
 | CYP1A2 activity** | ↑ | Human lymphocyte | Funck-Brentano et al. [22] | |
CAs | CYP2E1 mRNA* | ↑ | Human peripheral blood | Vodicka et al. [44] | |
8-OHdG | CYP1A1 activity | ↑ | Hepa1c1c7 cell | Park et al. [91] | |
 | CYP1A2 activity** | ↑ | Urine | ||
1-naphthol and dihydrodiol | CYP1A2 activity | ↑ | BTI-TN-5B1-4 cells | Cho et al. [25] | |
2-NT | CYP3A4 activity | ↑ | BTI-TN-5B1-4 cells | Cho et al. [25] | |
 | CYP2E1 mRNA** | ↑ | Human blood sample | Nan et al. [92] | |
Benzene | Total hydroxylated benzene metabolites | CYP2E1 and CYP2F1 activity** | All ↑ | Human BEAS-2B cells and Human A549 cells | Sheets et al. [52] |
 | CYP2E1 activity** | ↑ | Human liver sample | Nedelcheva et al. [49] | |
2-nitrophenol | CYP2E1 activity** | All ↑ | Human hepatic micromosome | Miksanova et al. [93] | |
Toluene | HA | CYP2E1 mRNA** | ↑ | Human lymphocytes and urine | Mendoza-Cantu et al. [58] |
Toluene metabolites | CYP2E1 and CYP1A2 activity** | ↑ | Human liver microsomes | Tassaneeyakul et al. [53] | |
Heterocyclic amines (HCAs) | Urinary unconjugated MeIQx | CYP1A2 activity** | ↑ | Urine | Sinha et al. [77] |
PhIP metabolites | CYP1A1 activity | ↑ | Sf9 insect cells | Crofts et al. [94] | |
HONH-PhIP | CYP1A2 activity | ↑ | Human liver sample | Langouet et al. [95] | |
Tobacco | Cotinine | CYP2A6 content** | ↑ | Human B-lymphoblastoid cells | Nakajima et al. [84] |
 | CYP2E1** activity | ↓ | Human microsomes | Van Vleet et al. [96] | |
 | CYP1B1 mRNA** | ↑ | Human peripheral blood | Hanaoka et al. [90] | |
 | CYP1A2 activity** | ↑ | Human lymphocyte and urine | Funck-Brentano et al. [22] | |
Nitro-samines | Induced revertants | CYP1A1, 2A6 and 2E1 activity | All ↑ | S. typhimurium YG7108 cells | Fujita and Kamataki [87, 88], Smith et al. [97], Kushida et al. [98] |
NNK and NNAL metabolites | CYP3A4 activity** | ↑ | Human hepatic microsomes | Staretz et al. [99] |